Recently, we have shown that the clinical spectrum associated with PCDH19 mutations can overlap that of Dravet syndrome (Depienne, et al., 2009). Here, PCDH19 is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.